Treace Medical Concepts Inc. (TMCI)

$4.81

up-down-arrow $-0.07 (-1.43%)

As on 04-Sep-2026 16:00EDT

Market cap

info icon

$313 Mln

Revenue (TTM)

info icon

$205 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

4.7

Div. Yield

info icon

0 %

Treace Medical Concepts (TMCI) Share Price

Compare

High: Low: Return:

Max: Min: Median:

Max: Min: Median:

loading...
loading...
loading...
loading...
loading...
loading...
loading...
loading...

Stock Range

Today’s Range

Low: 4.72 High: 4.89

52 Week Range

Low: 1.17 High: 7.63

Liquidityliquidity High

Low Moderate High

Fundamentals

  • Net Profit (TTM)Net Profit (TTM) information

    $0 Mln

  • ROEROE information

    -0.7 %

  • ROCEROCE information

    -- %

  • Industry P/EIndustry P/E information

    46.09

  • EV/EBITDAEV/EBITDA information

    -40.9

  • Debt to EquityDebt to Equity information

    0.8

  • Book ValueBook Value information

    $--

  • EPSEPS information

    $-0.9

  • Face valueFace value information

    --

  • Shares outstandingShares outstanding information

    65,034,552

5 Years Aggregate

CFO

$-94.58 Mln

EBITDA

$-96.00 Mln

Net Profit

$-132.99 Mln

Performance

Company
YTD
1 Month
3 Months
1 Year
3 Years
5 Years
10 Years
Treace Medical Concepts (TMCI)
96.3 2.8 41.5 -33.7 -32.4 -29.3 --
BSE Sensex*
-10.1 -3.6 2.5 -5.7 4.9 5.5 10.1
S&P Small-Cap 600#
-5.8 -5.3 -13.7 -6.3 5.3 3.0 5.5
As on 04-Sep-2026  |  *As on 07-Sep-2026  |  #As on 26-Oct-2023
Company
2025
2024
2023
2022
Treace Medical Concepts (TMCI)
-67.1 -41.4 -44.5 23.3
S&P Small-Cap 600
4.0 7.0 13.9 -17.4
BSE Sensex
9.1 8.1 18.7 4.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details
loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

loading...

*All values are in ($ Mln)

Key Ratios

View Details
loading...

loading...

loading...

5Y Avg -- 3Y Avg -- TTM --

loading...

P/E Ratio

--

--Min --Median --Max

loading...

P/B Ratio

--

--Min --Median --Max

loading...

Earnings Yield (%)

--

Earnings Yield (%) = EBIT / Enterprise value

PEG Ratio

--

Price = Price / Earnings to growth ratio

loading...

loading...

loading...

Peers

View Details
Company
Price ($) Market Cap ($ Mln) Revenue (TTM) Net Profit (TTM) OPM (%) ROE (%) P/E P/B
Treace Medical Concepts (TMCI)
4.8 312.8 205.3 -59.5 -26.2 -76.8 -- 4.7
62.7 8,162.7 616.9 -75.1 1.7 -9.3 -- 10.0
15.0 10,125.1 6,561.1 -578.0 -4.5 -10.3 -- 1.8
365.1 9,761.6 2,589.3 222.4 -6.0 3 44.5 1.4
58.5 8,913.0 3,499.6 -71.2 0.5 -3.2 -- 3.8
177.5 10,637.8 612.8 -188.1 -30.6 -28.1 -- 15.3
101.0 6,590.6 1,556.3 275.3 24.6 22.9 24.2 5.0
322.2 12,649.5 1,504.9 160.6 13.6 10.9 79.3 8.3
167.6 9,458.6 785.1 41.5 9.9 2 232.8 4.6
28.9 12,007.0 6,164.0 625.0 13.0 11.8 19.5 2.3

Shareholding Pattern

View Details
loading...
These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan

About Treace Medical Concepts (TMCI)

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity,...  stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deformity through a cosmetically appealing; and Percuplasty Percutaneous 3D Bunion Correction System that provides 3D correction of the bunion deformity through percutaneous incisions. It also provides Adductoplasty System, a system designed for the correction of metatarsus adductus deformities and osteoarthritis of the midfoot; SpeedMTP Rapid Compression Implant; SpeedPlate Implant Fixation Platform to address the fusion of larger bones of the midfoot and rearfoot; SpeedPlate Micro-Quad implant, an implant designed for stability and fit in small incision surgical approaches; and SpeedAkin Anatomic Compression Implant. In addition, the company offers The IntelliGuide patient specific instrumentation provides patient-specific, 3D-printed cut guides, and a pre-operative plan for a complete picture of the deformity and correction. Further, it provides FastGrafter Autografter Harvesting System; SpeedRelease Guided Release Instrument; TriTome Triple-Edge Release Instrument; RazorTome 7mm Precision Osteotome; LapiTome Hooked Bone Removal Osteotome; GreatRelease Rapid MTP Release Instrument; CornerChisel Release Tool; NanoRasp MIS Bone Contouring Tool; FeatherRasp Rapid Bone Contouring Instrument; and Akinator Single-cut Akin Wedge Osteotomy tool. Additionally, the company offers biologics and wedges, such as Treace Allograft Wedges; and CortiFuse Flowable Cortical Fibers. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. 

  • CEO, Founder & Director

    Mr. John T. Treace

  • CEO, Founder & Director

    Mr. John T. Treace

  • Headquarters

    Ponte Vedra, FL

  • Website

    https://www.treace.com

FAQs for Treace Medical Concepts (TMCI)

The share price of Treace Medical Concepts Inc (TMCI) is $4.81 (NASDAQ) as of 04-Sep-2026 16:00 EDT. Treace Medical Concepts Inc (TMCI) has given a return of -32.4% in the last 3 years.

Since, TTM earnings of Treace Medical Concepts Inc (TMCI) is negative, P/E ratio is not available.
The P/B ratio of Treace Medical Concepts Inc (TMCI) is 4.69 times as on 04-Sep-2026, a 24 premium to its peers’ median range of 3.78 times.


PE & PB ratio at the end of financial year.


Year P/E Ratio P/B Ratio
2025
-2.65
1.79
2024
-8.32
4.11
2023
-15.88
5.70
2022
-29.83
21.10
2021
-48.63
10.74

The 52-week high and low of Treace Medical Concepts Inc (TMCI) are Rs 7.63 and Rs 1.17 as of 08-Sep-2026.

Treace Medical Concepts Inc (TMCI) has a market capitalisation of $ 313 Mln as on 04-Sep-2026. As per SEBI classification, it is a Small Cap company.

Before investing in Treace Medical Concepts Inc (TMCI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.
Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.

loading...
loading...